Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein
Clinical Cancer Research, 08/08/2012
Crane CA et al. – The data provide the first evidence in humans of individual patient–specific immune responses against autologous tumor derived peptides bound to Heat shock protein (HSP)–96.



